TNF and inflammatory bowel disease: The unequal clinical efficacy of different anti-TNF agents between IBD and other chronic inflammatory diseases (e.g., rheumatoid arthritis) suggested that the effector mechanism of anti-TNF therapy in IBD may not be attributed to the TNF blockade alone (Levin et al., 2016).